BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10958598)

  • 1. A North Central Cancer Treatment Group phase II trial of topotecan in relapsed gliomas.
    Burch PA; Bernath AM; Cascino TL; Scheithauer BW; Novotny P; Nair S; Buckner JC; Pfeifle DM; Kugler JW; Tschetter LK
    Invest New Drugs; 2000 Aug; 18(3):275-80. PubMed ID: 10958598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of topotecan for relapsed ovarian cancer in accordance with the National Institute for Clinical Excellence Guidance 2001: the Nottingham experience.
    Anand A; Chan SY
    Clin Oncol (R Coll Radiol); 2004 Dec; 16(8):543-8. PubMed ID: 15630848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel.
    Bookman MA; Malmström H; Bolis G; Gordon A; Lissoni A; Krebs JB; Fields SZ
    J Clin Oncol; 1998 Oct; 16(10):3345-52. PubMed ID: 9779711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II trial of topotecan in patients with advanced, persistent, or recurrent endometrial carcinoma: a gynecologic oncology group study.
    Miller DS; Blessing JA; Lentz SS; Waggoner SE
    Gynecol Oncol; 2002 Dec; 87(3):247-51. PubMed ID: 12468321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of topotecan in advanced gastric cancer: a Southwest Oncology Group study.
    Benedetti JK; Burris HA; Balcerzak SP; Macdonald JS
    Invest New Drugs; 1997; 15(3):261-4. PubMed ID: 9387050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II evaluation of topotecan for pediatric central nervous system tumors.
    Blaney SM; Phillips PC; Packer RJ; Heideman RL; Berg SL; Adamson PC; Allen JC; Sallan SE; Jakacki RI; Lange BJ; Reaman GH; Horowitz ME; Poplack DG; Balis FM
    Cancer; 1996 Aug; 78(3):527-31. PubMed ID: 8697400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of topotecan in patients with advanced, persistent, or recurrent uterine leiomyosarcomas: a Gynecologic Oncology Group Study.
    Miller DS; Blessing JA; Kilgore LC; Mannel R; Van Le L
    Am J Clin Oncol; 2000 Aug; 23(4):355-7. PubMed ID: 10955863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II evaluation of topotecan in patients with advanced colorectal cancer. A Southwest Oncology Group trial (SWOG 9241).
    Macdonald JS; Benedetti JK; Modiano M; Alberts DS
    Invest New Drugs; 1997; 15(4):357-9. PubMed ID: 9547679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study of higher dose weekly topotecan in relapsed small-cell lung cancer.
    Spigel DR; Greco FA; Burris HA; Shipley DL; Clark BL; Whorf RC; Arrowsmith ER; Hainsworth JD
    Clin Lung Cancer; 2011 May; 12(3):187-91. PubMed ID: 21663862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral topotecan in children with recurrent or progressive high-grade glioma: a Phase I/II study by the German Society for Pediatric Oncology and Hematology.
    Wagner S; Erdlenbruch B; Längler A; Gnekow A; Kühl J; Albani M; Völpel S; Bucsky P; Emser A; Peters O; Wolff JE
    Cancer; 2004 Apr; 100(8):1750-7. PubMed ID: 15073866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topotecan in previously treated advanced urothelial carcinoma: an ECOG phase II trial.
    Witte RS; Manola J; Burch PA; Kuzel T; Weinshel EL; Loehrer PJ
    Invest New Drugs; 1998; 16(2):191-5. PubMed ID: 9848585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II evaluation of topotecan in carcinosarcoma of the uterus: a Gynecologic Oncology Group study.
    Miller DS; Blessing JA; Schilder J; Munkarah A; Lee YC
    Gynecol Oncol; 2005 Aug; 98(2):217-21. PubMed ID: 15975641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity and pharmacodynamics of 21-Day topotecan infusion in patients with ovarian cancer previously treated with platinum-based chemotherapy. New York Gynecologic Oncology Group.
    Hochster H; Wadler S; Runowicz C; Liebes L; Cohen H; Wallach R; Sorich J; Taubes B; Speyer J
    J Clin Oncol; 1999 Aug; 17(8):2553-61. PubMed ID: 10561322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized phase II study of daily versus continuous-infusion schedules of topotecan in the treatment of extensive-stage small cell lung cancers.
    Schaefer PL; Marks RS; Mahoney MR; Sloan JA; Bauman MD; Tazelaar HD; Kugler JW; Mailliard JA; Ebbert LP; Wiesenfeld M
    Am J Clin Oncol; 2003 Jun; 26(3):236-40. PubMed ID: 12796591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of topotecan in resistant and relapsing multiple myeloma: a Southwest Oncology Group study.
    Kraut EH; Crowley JJ; Wade JL; Laufman LR; Alsina M; Taylor SA; Salmon SE
    J Clin Oncol; 1998 Feb; 16(2):589-92. PubMed ID: 9469346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topotecan as salvage therapy for relapsed or refractory primary central nervous system lymphoma.
    Voloschin AD; Betensky R; Wen PY; Hochberg F; Batchelor T
    J Neurooncol; 2008 Jan; 86(2):211-5. PubMed ID: 17896078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topotecan in squamous cell carcinoma of the cervix: A Phase II study of the Gynecologic Oncology Group.
    Bookman MA; Blessing JA; Hanjani P; Herzog TJ; Andersen WA
    Gynecol Oncol; 2000 Jun; 77(3):446-9. PubMed ID: 10831357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topotecan treatment of adults with primary malignant glioma. The Brain Tumor Center at Duke.
    Friedman HS; Kerby T; Fields S; Zilisch JE; Graden D; McLendon RE; Houghton PJ; Arbuck S; Cokgor I; Friedman AH
    Cancer; 1999 Mar; 85(5):1160-5. PubMed ID: 10091802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phase II study of topotecan in patients with squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Muderspach LI; Blessing JA; Levenback C; Moore JL
    Gynecol Oncol; 2001 May; 81(2):213-5. PubMed ID: 11354055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long time therapy with topotecan in patients with recurrence of ovarian carcinoma.
    Möbus V; Pfaff PN; Volm T; Kreienberg R; Kaubitzsch S
    Anticancer Res; 2001; 21(5):3551-6. PubMed ID: 11848522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.